Ilunocitinib

Modify Date: 2024-01-10 08:18:05

Use of Ilunocitinib

Ilunocitinib (compound 27) is a JAK inhibitor (extracted from patent WO2009114512A1)[1].

Name	Ilunocitinib

Description	Ilunocitinib (compound 27) is a JAK inhibitor (extracted from patent WO2009114512A1)[1].
Related Catalog	Signaling Pathways >> JAK/STAT Signaling >> JAK Signaling Pathways >> Epigenetics >> JAK Signaling Pathways >> Stem Cell/Wnt >> JAK Research Areas >> Others
References	[1]. James D. Rodgers, et al. Azetidine and cyclobutane derivatives as jak inhibitors. Patent. WO2009114512A1.

Molecular Formula	C₁₇H₁₇N₇O₂S
Molecular Weight	383.43

Get all suppliers and price by the below link:

Dichloromethane
CAS#:75-09-2

Polyacrylic acid
CAS#:9003-01-4

sodium carbonate
CAS#:497-19-8

Silicon dioxide
CAS#:7631-86-9

Triethanolamine
CAS#:102-71-6

Demeton
CAS#:126-75-0

Water
CAS#:7732-18-5

Diclofenac sodium
CAS#:15307-79-6

Budesonide
CAS#:51372-29-3